procedures were defined if the patients had received repeated TEVAR, open repair for TBAD, embolization for endoleak, or open repair for retrograde type A aortic dissection after TEVAR or MMA. The timing of reintervention or late intervention was estimated on the basis of Kaplan-Meier analysis, and predictors were determined using Cox regression analysis.
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Aneurysm Sac Thrombus Volume Predicts Endoleak With Aneurysm Expansion After Endovascular Aneurysm Repair
Takayuki Fujii, Hiroshi Banno, Noriko Takahashi, Masayuki Sugimoto, Kiyoaki Niimi, Kimihiro Komori. Nagoya University Graduate School of Medicine, Nagoya, Japan
Objective: Several studies have analyzed risk factors that may influence the incidence of endoleak with sac expansion after endovascular aneurysm repair (EVAR) . Previous studies demonstrated a quantitative protective effect of intraluminal thrombus for endoleak. However, they assessed the amount of intraluminal thrombus indirectly by thrombus thickness, percentage of circumferential luminal thrombus, thrombus area, and so on. Therefore, the correlation still has not been well demonstrated. The aim of this study was to examine the correlation of preoperative intraluminal thrombus, measured by thrombus volume, with the incidence of endoleak and late sac expansion.
Methods: Between June 2007 and March 2014, there were 423 patients who underwent EVAR at our institution. Ruptured, inflammatory, and infected aneurysms were excluded; 214 patients who had preoperative and postoperative computed tomography angiography (CTA) and at least 3 years of follow-up were included in this study. Prospectively collected data were supplemented with a retrospective review of medical records and radiologic images. The demographic and clinical characteristic profiles were collected. CTA was evaluated with Aquarius iNtuition software (TeraRecon, Foster City, Calif) to obtain aneurysm sac, intraluminal thrombus volume, and other anatomic factors. Late endoleak was defined as a leak observed at 30 days. Significant abdominal aortic aneurysm sac expansion was defined as an increase of 5 mm. Logistic regression and Cox regression analysis were used to assess the association of each variable with the incidence of late endoleak and sac expansion.
Results: Of 214 patients, 49.1% (105 patients) had late endoleak and 19.6% (48 patients) had late endoleak with sac expansion on CTA. The mean follow-up duration was 53.4 months (range, 18.5-109.4 months). Univariate analysis demonstrated that number of total patent lumbar arteries (P ¼ .011), a patent inferior mesenteric artery (IMA; P < .01), diameter of IMA (P < .01), Excluder (W. L. Gore & Associates, Flagstaff, Ariz) stent graft (P < .01), smoking history (P ¼ .022), and preoperative intraluminal thrombus volume/sac volume (P ¼ .018) are significant factors regarding the incidence of late endoleak . Logistic regression analysis showed that variables such as diameter of IMA (P ¼ .006), Excluder stent graft use (P < .01), and preoperative intraluminal thrombus volume/sac volume (P ¼ .026) are predictors of incidence of late type II endoleak. Cox regression analysis showed that the preoperative intraluminal thrombus volume/ sac volume is the only significant predictor of incidence of late endoleak with sac expansion (P ¼ .015).
Conclusions: Preoperative aneurysm sac thrombus volume predicts incidence of endoleak with aneurysm expansion after EVAR. Objective: The conventional technique for the treatment of chronic venous insufficiency of the great saphenous vein (GSV) and small saphenous vein consists of high ligation of the saphenofemoral or saphenopopliteal junction accompanied by stripping. Intervention on the GSV has been advocated to stripping of the above-knee GSV because of saphenous nerve injury of GSV stripping. However, in our country, complete removal of the GSV is considered the standard of care. Our objective was to compare treatment of GSV reflux using radiofrequency (RFA) ablation compared with ligation and complete stripping (S&T), from the saphenofemoral junction to the ankle, in patients with chronic venous disease (CVD) and Clinical, Etiology, Anatomy, and Pathophysiology (CEAP) classes 2 to 4.
Methods: Forty-nine patients with CVD and CEAP class 2 to 4 were assessed at baseline, 4 weeks, and 1 year for complications, period of absence from activities, and calculation of the revised Venous Clinical Severity Score and quality of life scores. They were re-examined at 1 year and 3 years after treatment to evaluate recurrence rates.
Results: There were 186 patients referred from primary ambulatory care, of whom 70 (37.6%) met the eligibility criteria; 53 (28.6%) consented to participate. Four patients were excluded after randomization. The final analysis included 49 patients with primary CVD of the saphenous veins, with 26 randomly assigned to the RFA group and 23 to the S&T group. The success rate per limb (P ¼ .540), Venous Clinical Severity Score (P ¼ .636), Aberdeen Varicose Vein Questionnaire score (P ¼ .163), and clinical complications were similar in the two treatment groups. Nevertheless, the S&T group reported a longer time of absence from work or from domestic activities (20.13) than those in the RFA group (8.62). Length of hospitalization was also significantly longer for the S&T group (1.48) than for the RFA group (0.69; P < .0001). The clinical recurrence of varicose veins in 3 years was not significantly different in the two groups (P ¼ .638), with only two cases in the RFA group (8.7%) and three cases in the S&T group (15.8%).
Conclusions: The use of a minimally invasive technique by RFA for the treatment of saphenous reflux with CEAP classes 2, 3, and 4 had a success rate of around 94%. The patients who underwent this procedure displayed improvement in quality of life compared with the traditional technique but spent significantly less time hospitalized and absent from work.
